ODYSSEY THERAPEUTICS INC (ODTX)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$28.76+8.94%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
A structured standing thesis is not available for this company yet. The current Outlook below remains available.
Source: QuarterlyIQ standing thesis · Status: Not available
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This is a speculative growth investment focused on the healthcare sector. The current thesis state is characterized by low confidence due to recent earnings misses and an elevated risk of future misses.
The market appears to have a low fragility tier, indicating that it does not expect significant volatility in ODTX's stock. However, there is a cautious sentiment due to the company's recent performance and the potential for further earnings misses.
Management is on track with its cash runway and expense control, but the increased net loss raises concerns. The trajectory of clinical development for OD-001 and OD-002 is mixed, which may impact future performance.
The long-term thesis hinges on the company's ability to advance clinical trials without further guidance cuts. Additionally, the performance of sector bellwethers and broader economic indicators like job reports will influence ODTX's trajectory.
In the next 1 to 3 years, ODTX's outlook will depend heavily on clinical developments and market conditions. Not investment advice.
The most important moves since the prior daily snapshot.
Our read on the company is unchanged since the prior snapshot.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.